Test right, once.
SalivIQ™ Strep A is the only saliva-based diagnostic test for strep throat. Results in as little as 22 minutes, with no throat swab and no follow-up culture.
why testing matters
Strep
throat
is
the
only
sore
throat
that
needs
antibiotics.
Rapid
tests
still
miss
too
many
of
them.
100%
accurate across 102 clinical samples
the solution
The SalivIQ™ Strep A advantage
Accurate
100% sensitive and 100% specific against throat culture in clinical validation, so a follow-up culture is no longer necessary.
Fast
Results in as little as 22 minutes, inside the same visit, so treatment can begin before the patient leaves.
Preferred
Saliva was the most preferred sample type in a 2,100-person global survey, and parents preferred it for their children.
Simple
No specialized training required. Go from saliva to result in two steps on compact next-generation qPCR equipment.
Julia Halterman, PhD
Founder & CEO
why we built it
There had to be a better way
We know how uncomfortable strep testing is, and we have seen how distressing it is for children to have a sore throat swabbed. Rapid strep tests have been in use for over 40 years and are notorious for false negatives. So we built a saliva protocol on next-generation qPCR that is quick, inexpensive, and precise.
the problem
Millions of patients are treated on a guess
Throat swab, or saliva
Today’s standard
SalivIQ™ Strep A
No swab. No gagging.
Children refuse throat swabs. A saliva sample takes seconds and needs no cooperation.
15M
Outpatient visits for sore throat each year in the US
50% are prescribed antibiotics
25% actually need them
22 min
To result
Same visit. No follow-up culture.
Built for the point of care
Compact next-generation qPCR that runs in the clinic, with no specialized training required.
14.4%
False-negative rate of current rapid strep tests
clinical validation
Validated against the diagnostic standard
102 saliva samples were collected at the James Madison University Health Center and run through the SalivIQ™ Strep A protocol. Measured against throat culture, the current diagnostic standard, every result agreed.
Published in Diagnosis, 2024
where we are
Milestones on the way to the clinic
January 2026
Seed round led by Queen City Angels
Queen City Angels is the lead investor in the SalivIQ Seed round.
January 2026
Southwest National Pediatric Device Consortium
SalivIQ joined the SWPDC as a portfolio company.
April 2025
Second FDA pre-submission completed
A second pre-submission meeting returned actionable regulatory feedback.
April 2025
Manufacturing partner secured
Life Science Outsourcing will manufacture the flagship test.
Talk to us
Tell us about your clinic or your interest, and we will come back to you.
FAQs
Frequently asked questions
Still have questions?
Our team is here to help. Get in touch and we will answer directly.
How does SalivIQ™ Strep A work?
A patient provides a small saliva sample. The sample runs on next-generation quantitative PCR, which detects the DNA of group A Streptococcus, the bacteria that causes strep throat. There is no throat swab at any stage.
How long do results take?
How accurate is it?
Does it need special training or equipment?
Where is SalivIQ in the regulatory process?